BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,752 | -99.6% | 2,669 | -98.9% | 0.00% | -100.0% |
| Q2 2023 | $1,611,440 | -4.8% | 241,958 | +199.1% | 0.01% | -28.6% |
| Q1 2022 | $1,692,000 | -54.6% | 80,900 | -68.3% | 0.01% | -65.0% |
| Q4 2019 | $3,726,000 | +152.1% | 255,000 | +21.4% | 0.02% | +122.2% |
| Q3 2019 | $1,478,000 | +912.3% | 210,000 | +1001.7% | 0.01% | +800.0% |
| Q3 2018 | $146,000 | -75.9% | 19,062 | -71.0% | 0.00% | -50.0% |
| Q2 2018 | $605,000 | -0.7% | 65,809 | +10.7% | 0.00% | -33.3% |
| Q1 2018 | $609,000 | – | 59,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |